Aquilo Capital Management, LLC Synlogic, Inc. Transaction History

Aquilo Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$2.12 - $9.37 $2.21 Million - $9.78 Million	-1,043,922 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.27 - $9.48 $2.21 Million - $3.35 Million	-353,094 Reduced 25.27%	1,043,922 $9.5 Million
Q1 2019 May 15, 2019	BUY	$7.01 - $10.24 $440,487 - $643,450	62,837 Added 4.71%	1,397,016 $10.6 Million
Q4 2018 Feb 14, 2019	BUY	$5.95 - $14.49 $2 Million - $4.87 Million	336,145 Added 33.68%	1,334,179 $9.35 Million
Q3 2018 Nov 14, 2018	BUY	$7.51 - $14.21 $5.19 Million - $9.82 Million	691,240 Added 225.31%	998,034 $14.2 Million
Q2 2018 Aug 14, 2018	BUY	$9.01 - $13.33 $2.76 Million - $4.09 Million	306,794 New	306,794 $3.02 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $96.9M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aquilo Capital Management, LLC with notifications on news.